Launches its revolutionary antibiotic with highest purity - Purimox®
from the DSM Pure Actives TM portfolio
Toansa, Punjab, India August 23, 2006: Global leader DSM
Anti-Infectives today announced the launch of its breakthrough technology in
India, in succession to its first production facility in Spain with the
introduction of Purimox® an antibiotic with highest purity.
Speaking on the occasion of the introduction of Purimox®, Mr. Gerard De
Reuver, President, DSM Anti-Infectives said, “We have a long-term commitment
to India. DSM is proud to be in India, a country that has recognized the value
and importance of a strong biomedical and pharmaceutical industry. We will
follow DSM’s inherent commitment to its relentless pursuit of scientific
excellence and innovation. India, over the years has become an important
market with and the new plant is part of our expansion plans to have a strong
footing in the region.’’
Purimox®, a penicillin based antibiotic, is from the DSM Pure ActivesTM family
of environmental friendly products. Purimox® was introduced in Toansa, Punjab
by Mr. Gerard De Reuver, the President of DSM Anti-Infectives. Conventionally,
amoxicillin is produced in a synthetic process using strong solvents and
chemicals.
Purimox® is a technological breakthrough as it produces amoxicillin in an
enzymatic route without use of solvents, leading to a product of higher purity
and lesser impurities. Through the launch of production of Purimox® in India,
DSM is making available to the pharmaceutical companies in Asia-Pacific/Middle
East/ Africa and therefore to consumers, a safe product made in an effective
and sustainable way.
Mr. N.V. Ramanan, Vice President, DSM Anti-Infectives, added: “DSM’s continued
and serious commitment to being a leader in the sector of anti-infectives has
seen us continuously investing in breakthrough research to develop novel
technologies. With the inauguration of this plant, we have strengthened the
bond with our Asia Pacific, Middle East and African customers, providing them
with a plant committed fully to the manufacturing of Purimox®. It is an
antibiotic which will transfigure the standards of product purity leading to
healthier and safer life.’’
DSM Anti-Infectives inaugurated the Purimox® plant at Toansa, Chandigarh,
India which would be completely dedicated to the manufacturing of Purimox®.
The plant would be dedicated to meet demand across Asia-Pacific, Middle East
and Africa.
DSM India
Total turnover of DSM in India is $ 150 mn and
currently as part of DSM’s strategy Vision 2010 – building on strengths it is
engaged in a project to expand DSM’s operations in India.
DSM’s companies in India are engaged in a variety of social activities. To
tackle malnutrition, DSM has started a humanitarian project by supplying
capsules of Vitamin A. DSM Anti-Infectives also continuously participates in
community welfare and developmental projects in and around Toansa where its
plant is located. India is also the focus area of the base of the pyramid
(BOP) activities that DSM is developing and promoting. DSM Anti-Infectives has
also established a global sourcing operation, centered on emerging markets in
India. As a demonstration of faith in India, they have established the Asia
Pacific Middle East operations out of Gurgaon.
DSM
DSM is active worldwide in nutritional and pharma
ingredients, performance materials and industrial chemicals. The company
creates innovative products and services that help improve the quality of
life. DSM’s products are used in a wide range of end markets and applications
such as human and animal nutrition and health, cosmetics, pharmaceuticals,
automotive and transport, coatings, housing and electrics & electronics (E&E).
DSM’s strategy, named Vision 2010 – Building on Strengths, focuses on
accelerating profitable and innovative growth of the company’s specialties
portfolio. Market-driven growth, innovation and increased presence in emerging
economies are key drivers of this strategy. The group has annual sales of over
EUR 8 billion and employs some 22,000 people worldwide. DSM ranks among the
global leaders in many of its fields. The company is headquartered in the
Netherlands, with locations in Europe, Asia, Africa and the Americas. More
information about DSM can be found at www.dsm.com
.
